Triple negative breast cancer (TNBC) accounts for 10–20 % of all breast carcinomas and is characterized by the absence of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER-2) [1]. Here, ESR1 is linked to triple-negative breast carcinoma.